Health Care & Life Sciences » Pharmaceuticals | Stallergenes Greer PLC

Stallergenes Greer PLC | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
58,142.00
59,971.00
73,863.00
96,049.00
9,871.00
Depreciation, Depletion & Amortization
12,568.00
12,794.00
12,892.00
25,247.00
22,946.00
Other Funds
1,089.00
1,882.00
-
-
-
Funds from Operations
52,789.00
54,099.00
57,576.00
70,749.00
17,835.00
Changes in Working Capital
23,620.00
2,420.00
18,998.00
7,919.00
23,460.00
Net Operating Cash Flow
29,169.00
56,519.00
38,578.00
78,668.00
5,625.00
Capital Expenditures
9,786.00
16,977.00
17,268.00
22,015.00
12,643.00
Sale of Fixed Assets & Businesses
21.00
25.00
2,018.00
19,509.00
5,269.00
Purchase/Sale of Investments
-
732.00
-
-
-
Net Investing Cash Flow
11,105.00
19,853.00
187,557.00
5,053.00
10,177.00
Cash Dividends Paid - Total
10,142.00
10,279.00
-
-
-
Issuance/Reduction of Debt, Net
1,774.00
-
1,511.00
4,964.00
3,186.00
Net Financing Cash Flow
1,117.00
3,395.00
793.00
4,984.00
3,258.00
Net Change in Cash
16,601.00
33,337.00
150,125.00
78,921.00
20,413.00
Free Cash Flow
19,383.00
50,120.00
55,846.00
100,683.00
18,268.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
1,663.00
Net Assets from Acquisitions
-
-
-
-
1,403.00
Other Sources
-
1,075.00
202,807.00
-
-
Change in Capital Stock
9,710.00
8,766.00
718.00
20.00
72.00
Exchange Rate Effect
346.00
66.00
353.00
184.00
1,353.00
Other Uses
1,340.00
3,244.00
-
2,547.00
1,400.00

About Stallergenes Greer

View Profile
Address
40 Bernard Street
London Greater London WC1N 1LE
United Kingdom
Employees -
Website http://stallergenes.co.uk
Updated 09/14/2018
Stallergenes Greer Plc is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. It operates through the following geigraphical segments: Southern Europe; Northern and Central Europe; Internation Markets; and United States.